Short answer
Prime Medicine, Inc. (PRME) filed an 8-K current report with the SEC on June 8, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). 140,384,724 shares represented, establishing quorum from 180,615,889 shares outstanding.
Prime Medicine, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- 140,384,724 shares represented, establishing quorum from 180,615,889 shares outstanding
- Michael Kelly and David Schenkein elected Class I directors through 2029
- Schenkein received 87,522,409 votes for versus 22,584,594 withheld, indicating comparatively weaker shareholder support
- PwC ratified as independent auditor for fiscal 2026 with 139,989,201 votes for and 101,259 against
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Prime Medicine, Inc. 8-K filings
Get the next PRME 8-K as it lands
Follow PRME for push alerts, or ask the research agent what this filing means.